Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects
The majority of drugs are typically orally administered. The journey from drug discovery to approval is often long and expensive, involving multiple stages. A major challenge in the drug development process is drug-induced liver injury (DILI), a condition that affects the liver, the organ responsibl...
Saved in:
| Main Authors: | Dileep G. Nair, Ralf Weiskirchen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Current Issues in Molecular Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1467-3045/47/1/7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Progress in PDMS-Based Microfluidics Toward Integrated Organ-on-a-Chip Biosensors and Personalized Medicine
by: Fahad Alghannam, et al.
Published: (2025-01-01) -
Deciphering respiratory viral infections by harnessing organ-on-chip technology to explore the gut–lung axis
by: Hristina Koceva, et al.
Published: (2025-03-01) -
Hepatotoxicity evaluation of cannabidiol, cannabinol, cannabichromene and cannabigerol using a human quad culture liver chip
by: Jacob D. Larson, et al.
Published: (2025-08-01) -
Exploring drug-induced liver injury: comprehensive insights into mechanisms and management of hepatotoxic agents
by: Ahmed K. Saleh, et al.
Published: (2025-03-01) -
Organ-on-a-Chip Applications in Microfluidic Platforms
by: Ling An, et al.
Published: (2025-02-01)